Fully Automated Production of 68 Ga-DOTA-NOC with a Trasis miniAIO ® Synthesizer. Marc Léonard Joël Aerts 1, Samuel Voccia², Christian Lemaire 1,

Slides:



Advertisements
Similar presentations
Radiopharmaceutical Production
Advertisements

LC-ESI-MS/MS analysis of nine basic pharmaceuticals in influent, effluent and surface water Jet C. Van De Steene and Willy E. Lambert Laboratory of Toxicology,
Sample clean-up (MALDI)
You can hardly find water which has no problem with one of 5 typical contaminants: Hardness Iron Manganese Natural organic matter (NOM) Smell of ammonia.
Radiopharmaceutical Production
Caffeine as a Surrogate for Cocaine in an HPLC Forensic Experiment Ray A. Gross Jr, Indravadan Shah and Muhamed Jasarevic Department of Physical Sciences.
ION EXCHANGE CHROMATOGRAPHY PREPARED BY- MD.MARUF HASSAN.
Conclusions Optimum conditions for derivatization were: methanol as solvent for reagent I, K 3 [Fe(CN) 6 ] 0.02M, DPE 0.05M, methanol: HCl: water 14:1:15.
SODIUM BOROHYDRIDE REDUCTION OF A KETONE
Assignment: water.
Gradient Manipulation and 1.8 µm LC Columns for High Resolution Analysis of Herbal Supplements John W Henderson Jr, Thierry Faye, Ulrik Witteg, Maureen.
OXIDATION OF 9-FLUORENOL
Preparing Solutions. Short Form  Obtain the required amount of ingredients  Dissolve them  Bring to volume (q.s.)  Store.
Lab Activity 7 Proteins Part I IUG, 2015 Dr. Tarek Zaida 1.
Quiz Time 05:00 04:0003:0002:0001:3001:0000:4500:3000:1500:00.
Gel filtration Chromatography
Preparing Solutions. Short Form  Obtain the required amount of ingredients  Dissolve them  Bring to volume (q.s.)  Store.
Calculate the pH of a solution that is 0.20 M in NaCH 3 COO and 0.10 M in CH 3 COOH
 Amino acid analysis refers to the methodology used to determine the amino acid composition or content of proteins, peptides, and other pharmaceutical.
B IOCHEMICAL INSTRUMENTAL ANALYSIS -11 Dr. Maha Al-Sedik.
Henderson – hasselbalch equation
REDUCTION OF 9-FLUORENONE
II III I II. Concentration Solutions. A. Concentration  The amount of solute in a solution.  Describing Concentration % by mass - medicated creams %
Hemicellulose: 47% Cellulose: 15% Lignin (van Soest): 8% Proteins: 12% A multi-step process for an alternative wheat bran biorefinery Wheat bran (WB) is.
Schmitz F., Van Gansbeke B., Monclus M., Van Naemen J., Kadiata M., Ekelmans D., Goldman S. 1 PET/Biomedical Cyclotron Unit, ULB-Hospital Erasme, Route.
Southern Taiwan University Development of High Efficiency Purification Method of Recombinant EGFP Proteins with New Immobilized Metal Ion Affinity Chromatography.
Water for Pharmaceutical Use Part 2: Water purification engineering
Thursday, March 6, 2008 Discussion of Molarity Lab Results Introduce Section 15.2b -- Dilutions Homework: Pg. 555, #31a-d, 32, 33, 34.
Molarity by Dilution Diluting Acids How to Calculate Acids in concentrated form are diluted to the desired concentration using water. Moles of acid before.
A general method for labeling siRNA by click chemistry with fluorine-18 for in vivo PET imaging Flagothier J 1, Mercier F 1, Kaisin G 1, Teller N 2, Warnock.
Novel approach to production of high specific activity [ 18 F]-Sodium Tetrafluoroborate Alex Khoshnevisan 1, Jennifer D. Young 1, Gareth E. Smith 2, Alex.
Preliminary Experiments: To obtain a range of redox potentials between -180 and -425 mV, varying concentrations of DTT (between 0.10 and 2.5 mM) were used.
INTRODUCTION Concentration-dependent peptide losses during the drying step in the sample preparation: influence of additives Adel Pezeshki 1,2, Valentijn.
Concentration/Molarity/Molar Concentration A measure of the amount of solute that is dissolved in a measured amount of solvent. Dilute: a solution that.
Gallium-68 – a candidate for use in clinical routine
Transport lines between the 18 O- H 2 O/[ 18 F]F- target and the synthesis device are a potential source of 19 F contamination in synthesis of 18 F- labelled.
1. How many grams of sucrose (Mr 342) would you need in order to make 500 mL of a 5 mM solution? 2. Assume a 36% (w/w) solution of protein (Mr )
Stability Indicating Assays for Dose Formulation Stability Testing Teresa Fuller GSK.
Peptides Martina Zlámalová. Peptide Synthesis Methodology is carried out by FMOC chemistry, using PEG-Polystyrene resins peptides are cleaved from the.
Biochemical instrumental analysis - 11 Dr. Maha Al-Sedik 2015 CLS 332.
NaBH4 Reduction of p-Vanillin
Supplementary Fig. S2 Elution profiles of amino acid derivatives in a UPLC system. The enzyme (1 μg) was incubated with 10 mM D -amino acid (2.5 mM D -Tyr)
OXIDATION OF 9-FLUORENOL
Analysis of aspirin Tablet
Experiment 19: OXIDATION OF 9-FLUORENOL. Objectives:  To synthesize a ketone from a secondary alcohol using household bleach.  To purify product using.
Upon receiving the generator, the system was flushed the with TraceSELECT Ultra 0.6 M HCl solution (10-20 ml). Sixty eight min after the former elution.
Molarity & Dilutions. Molarity Concentration – Measure of the amount of solute that is dissolved in a given quantity of solvent Dilute solution – Contains.
Exp 4A: Conductivity Of Aqueous Solutions Purpose –Study conductivity of a series of solutions to determine the difference between strong electrolytes,
Improved Radiochemical Yields, Reliability and Improvement of Domestic [ 18 F]FDG Auto Synthesizer J. H. PARK, K.S. IM, H.J. Lee, B.C. Lee, I.W Lee Department.
% € $ Multiresidue analysis of 25 pesticide residues in wines
Trabajo Final de Máster Submitted by Hazem Essam Elsayed Okda
8.7 Making Molar Solutions
MICROENCAPSULATION OF FISH OIL BY
Chromatographic condition
Dilution Chapter 15 Ch 15 ppt 3 - Dilution.ppt
Procedures for the GMP-Compliant Production and Quality Control of [18F]PSMA-1007: A Next Generation Radiofluorinated Tracer for the Detection of Prostate.
The common lysis solutions contain A. sodium chloride.
Ch Concentration Units
Dnyanasadhana College, Thane. Department of Chemistry M. Sc
Unit 5: Acid-Base Calculations Lesson 4: Mixing Strong Acids + Bases
Lab Activity 7 Proteins Part I
Solution Concentration
Extraction Procedure (2)
Solutions and Solubility
Concentrations of Solutions
Diluting Solutions Lesson 6.
Radiochemistry Solutions
Molecular Therapy - Nucleic Acids
Solution Concentration
Levofloxacin structural formula
Presentation transcript:

Fully Automated Production of 68 Ga-DOTA-NOC with a Trasis miniAIO ® Synthesizer. Marc Léonard Joël Aerts 1, Samuel Voccia², Christian Lemaire 1, Jean Luc Morelle 2, Gauthier Philippart 2 and André Luxen 1 1 Centre de Recherches du Cyclotron, Université de Liège, BELGIUM 2 Trasis SA, Ans, BELGIUM Aim Results and conclusion Our objective was to develop a fast and reproducible fully automated method for the preparation of 68 Ga-labelled DOTA-peptide with the miniAIO® synthesis module made by Trasis SA (Figure 1). The labelling of an easily commercially available peptide, DOTA-NOC, was designated as a proof of concept for this purpose. The synthesis of 68 Ga-DOTA-NOC was performed on a miniAIO ® synthesizer which has several advantages: using single-use cassettes (Figure 2), monitoring the radiosynthesis by means of radioactivity detectors (Figure 4) and being small and easily implantable in GMP hot cells. The leachable of metallic contaminants was taken in account for the choice of the cassette materials. The synthesis includes the following steps: Elution of 68 Ga from a 68 Ge/ 68 Ga generator with 8 mL of a HCl solution. Two different generators were tested: iThemba‘s 370 MBq eluted with 0.6N HCl and Eckert-Ziegler‘s 1850 MBq eluted with 0.1N HCl (Figure 1). The eluate was saturated with NaCl and then passed through a strong anion exchange resin (Waters OASIS MAX) to concentrate 68 GaCl 4- (method derived from [1]). 68 Ga was then eluted from the resin with 200 µL of physiologic liquid (NaCl 0,9%) directly into the reaction vial containing the peptide solubilized in acetate buffer. The mixture was heated at 95°C for 7 min. The crude reaction media was passed through a hydrophilic/lipophilic resin (Waters OASIS HLB) and the resin was rinsed with NaCl 0,9% to remove free 68 Ga Ga-DOTA-NOC was eluted with 0.5 mL of ethanol and diluted with NaCl 0.9% and filtered with a 0.22 µm filter. The quality of the product was assessed by UHPLC with UV and radiochemical detection, GC, pH determination. 68 Ga-DOTA-NOC was obtained with reproducible yields of 60% (decay corrected, calculated on the total activity eluted from the generator) within 25 minutes including generator elution, clean-up and concentration of the eluate, radiolabeling, final SPE purification and formulation. Radiochemical purity was > 99.5% (Figure 3) ; ethanol concentration < 10% v/v ; acetic acid content < 5000 ppm ; pH between 4.5 and 7.0. No 68 Ge was detected in the vial after decay of 68 Ga by gamma spectroscopy. Using miniAIO ®, the method described allows a safe, fast and reliable synthesis of 68 Ga-DOTA-NOC from a 68 Ge/ 68 Ga generator and should be easily transposable for the production of any other 68 Ga-labelled DOTA-peptides. Acknowledgements We acknowledge the financial support from the BIOWIN Project of the Walloon Region (GaGe). Materials and methods Figure 1 : miniAIO® synthesis module and the two generators in use Figure 2 : 68 Ga-DOTA-NOC cassette layout Figure 3 : Radiochemical UHPLC profile of 68 Ga-DOTA-NOC ; Acquity UPLC BEH C18, 130Å, 1,7 µm, 2,1 mm X 50 mm ; Radio-detector : Berthold fLumo LB 500 ; flow at 0,6 ml/min : Time (min)TFA 0,1%Acetonitrile 090%10% 3 90% 3,510%90% 4 10% 690%10% Figure 4 : Typical radioactivity profile during a synthesis of 68Ga-DOTA-NOC on a miniAIO® synthesis module : blue: OASIS MAX cartridge ; green : reaction vial ; yellow : OASIS HLB - corresponding author : Download abstract here : References [1] Eur J Nucl Med Mol Imaging (2004) 31:1097– 1104